Natalie Prinzi

First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study

Sandra P. D’Angelo, Célèste Lebbé, Laurent Mortier et al. · Journal for ImmunoTherapy of Cancer · 2021 · 137 citations · Full text

Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues

Sara Pusceddu, Claudio Vernieri, Massimo Di Maïo et al. · Gastroenterology · 2018 · 87 citations · Full text

Oncology, Pancreatic Cancer, Medicine +8

Correlation between MGMT promoter methylation and response to temozolomide-based therapy in neuroendocrine neoplasms: an observational retrospective multicenter study

Davide Campana, Thomas Walter, Sara Pusceddu et al. · Endocrine · 2017 · 75 citations · Full text

Neuroendocrine Neoplasms, Epigenetic Regulation, Mgmt Promoter Methylation +9

Gastroenteropancreatic High-Grade Neuroendocrine Neoplasms: Histology and Molecular Analysis, Two Sides of the Same Coin

Adele Busico, Patrick Maisonneuve, Natalie Prinzi et al. · Neuroendocrinology · 2019 · 63 citations · Full text

Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors

Sara Pusceddu, Natalie Prinzi, Salvatore Tafuto et al. · JAMA Network Open · 2022 · 58 citations · Full text